{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ADPT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:25:23.574Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9563,"canonical_name":"Adaptive Biotechnologies Corp","cik":"0001478320","uei":null,"lei":null,"duns":null,"ticker":"ADPT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":113},"count":100,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-10-13","url_slug":"/sec/cik-0001478320/4/0001780664-26-000039","accession_number":"0001780664-26-000039","importance":30},{"ts":"2026-10-08","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-10-08","url_slug":"/sec/cik-0001478320/4/0001780664-26-000037","accession_number":"0001780664-26-000037","importance":30},{"ts":"2026-10-08","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-10-08","url_slug":"/sec/cik-0001478320/4/0001820885-26-000025","accession_number":"0001820885-26-000025","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-10-06","url_slug":"/sec/cik-0001478320/144/0001950047-26-010075","accession_number":"0001950047-26-010075","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-10-05","url_slug":"/sec/cik-0001478320/4/0001780660-26-000024","accession_number":"0001780660-26-000024","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-10-05","url_slug":"/sec/cik-0001478320/4/0001780664-26-000035","accession_number":"0001780664-26-000035","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-10-01","url_slug":"/sec/cik-0001478320/144/0001950047-26-009975","accession_number":"0001950047-26-009975","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-09-18","url_slug":"/sec/cik-0001478320/4/0001780660-26-000022","accession_number":"0001780660-26-000022","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-09-17","url_slug":"/sec/cik-0001478320/4/0001820885-26-000023","accession_number":"0001820885-26-000023","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-09-16","url_slug":"/sec/cik-0001478320/144/0001950047-26-009582","accession_number":"0001950047-26-009582","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-09-15","url_slug":"/sec/cik-0001478320/144/0001950047-26-009505","accession_number":"0001950047-26-009505","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-09-02","url_slug":"/sec/cik-0001478320/4/0001852578-26-000007","accession_number":"0001852578-26-000007","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-08-28","url_slug":"/sec/cik-0001478320/4/0001852578-26-000005","accession_number":"0001852578-26-000005","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-26","url_slug":"/sec/cik-0001478320/144/0001950047-26-008709","accession_number":"0001950047-26-008709","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-20","url_slug":"/sec/cik-0001478320/144/0001958244-26-000543","accession_number":"0001958244-26-000543","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-19","url_slug":"/sec/cik-0001478320/144/0001958244-26-000536","accession_number":"0001958244-26-000536","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-08-19","url_slug":"/sec/cik-0001478320/4/0001780649-26-000014","accession_number":"0001780649-26-000014","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-18","url_slug":"/sec/cik-0001478320/144/0001958244-26-000526","accession_number":"0001958244-26-000526","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-18","url_slug":"/sec/cik-0001478320/144/0001958244-26-000527","accession_number":"0001958244-26-000527","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-17","url_slug":"/sec/cik-0001478320/144/0001958244-26-000521","accession_number":"0001958244-26-000521","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-17","url_slug":"/sec/cik-0001478320/144/0001958244-26-000523","accession_number":"0001958244-26-000523","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-08-12","url_slug":"/sec/cik-0001478320/4/0001820885-26-000020","accession_number":"0001820885-26-000020","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-08-10","url_slug":"/sec/cik-0001478320/144/0001950047-26-007899","accession_number":"0001950047-26-007899","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Adaptive Biotechnologies Corp — 2026-08-04","url_slug":"/sec/cik-0001478320/10-q/0001193125-26-332940","accession_number":"0001193125-26-332940","importance":45},{"ts":"2026-08-03","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-08-03","url_slug":"/sec/cik-0001478320/4/0001820885-26-000018","accession_number":"0001820885-26-000018","importance":30},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"BOBULSKY SUSAN","title":"Chief Commercial Officer, MRD","shares":1299,"price_per_share":24,"usd_value":31176,"security_title":"Common Stock","importance":35.031176},{"ts":"2026-07-30","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-07-30","url_slug":"/sec/cik-0001478320/144/0001950047-26-007439","accession_number":"0001950047-26-007439","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Adaptive Biotechnologies Corp — 2026-07-29","url_slug":"/sec/cik-0001478320/8-k/0001193125-26-323753","accession_number":"0001193125-26-323753","importance":35},{"ts":"2026-07-23","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-07-23","url_slug":"/sec/cik-0001478320/4/0001780851-26-000017","accession_number":"0001780851-26-000017","importance":30},{"ts":"2026-07-21","kind":"sec.form144","reporter":"Harlan Robins","title":"Officer","shares":492400,"usd_value":11118392,"security_title":"Common Stock","approx_sale_date":"2026-07-21","accession_number":"0001958244-26-000463","importance":42.2236784},{"ts":"2026-07-21","kind":"sec.insider.s","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":278698,"price_per_share":21.72,"usd_value":6053321,"security_title":"Common Stock","importance":41.05332056},{"ts":"2026-07-21","kind":"sec.insider.s","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":213702,"price_per_share":22.12,"usd_value":4727088,"security_title":"Common Stock","importance":39.72708824},{"ts":"2026-07-21","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-07-21","url_slug":"/sec/cik-0001478320/144/0001958244-26-000463","accession_number":"0001958244-26-000463","importance":30},{"ts":"2026-07-21","kind":"sec.insider.278698","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":278698,"price_per_share":21.72,"usd_value":6053321,"security_title":"Common Stock","importance":21.05332056},{"ts":"2026-07-21","kind":"sec.insider.213702","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":213702,"price_per_share":22.12,"usd_value":4727088,"security_title":"Common Stock","importance":19.72708824},{"ts":"2026-07-21","kind":"sec.insider.284800","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":284800,"price_per_share":6.55,"usd_value":1865440,"security_title":"Common Stock","importance":16.86544},{"ts":"2026-07-21","kind":"sec.insider.m","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":284800,"price_per_share":6.55,"usd_value":1865440,"security_title":"Common Stock","importance":16.86544},{"ts":"2026-07-20","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-07-20","url_slug":"/sec/cik-0001478320/4/0001820885-26-000016","accession_number":"0001820885-26-000016","importance":30},{"ts":"2026-07-16","kind":"sec.form144","reporter":"SUSAN BOBULSKY","title":"Officer","shares":5000,"usd_value":114500,"security_title":"Common","approx_sale_date":"2026-07-16","accession_number":"0001950047-26-007171","importance":40.0229},{"ts":"2026-07-16","kind":"sec.insider.s","reporter":"BOBULSKY SUSAN","title":"Chief Commercial Officer, MRD","shares":5000,"price_per_share":23,"usd_value":115000,"security_title":"Common Stock","importance":35.115},{"ts":"2026-07-16","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-07-16","url_slug":"/sec/cik-0001478320/144/0001950047-26-007171","accession_number":"0001950047-26-007171","importance":30},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"LO FRANCIS","title":"Chief People Officer","shares":105762,"price_per_share":22.59,"usd_value":2389164,"security_title":"Common Stock","importance":37.38916358},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":59374,"price_per_share":7.8,"usd_value":463117,"security_title":"Common Stock","importance":15.4631172},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":23677,"price_per_share":12.14,"usd_value":287439,"security_title":"Common Stock","importance":15.28743878},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":22711,"price_per_share":8.46,"usd_value":192135,"security_title":"Common Stock","importance":15.19213506},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-07-07","url_slug":"/sec/cik-0001478320/4/0001780851-26-000015","accession_number":"0001780851-26-000015","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-07-06","url_slug":"/sec/cik-0001478320/4/0001780660-26-000017","accession_number":"0001780660-26-000017","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-07-06","url_slug":"/sec/cik-0001478320/4/0001820885-26-000014","accession_number":"0001820885-26-000014","importance":30},{"ts":"2026-07-02","kind":"sec.form144","reporter":"Harlan Robins","title":"Officer","shares":386240,"usd_value":8184426,"security_title":"Common Stock","approx_sale_date":"2026-07-02","accession_number":"0001958244-26-000428","importance":41.63688512},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":239351,"price_per_share":21.74,"usd_value":5203491,"security_title":"Common Stock","importance":40.20349074},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":146889,"price_per_share":22.45,"usd_value":3297658,"security_title":"Common Stock","importance":38.29765805},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"LO FRANCIS","title":"Chief People Officer","shares":44838,"price_per_share":22.59,"usd_value":1012890,"security_title":"Common Stock","importance":36.01289042},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-07-02","url_slug":"/sec/cik-0001478320/144/0001958244-26-000428","accession_number":"0001958244-26-000428","importance":30},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":12600,"price_per_share":12.14,"usd_value":152964,"security_title":"Common Stock","importance":15.152964},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":12637,"price_per_share":8.46,"usd_value":106909,"security_title":"Common Stock","importance":15.10690902},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":12626,"price_per_share":7.8,"usd_value":98483,"security_title":"Common Stock","importance":15.0984828},{"ts":"2026-07-01","kind":"sec.form144","reporter":"FRANCIS LO","title":"Officer","shares":199260,"usd_value":4274127,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006726","importance":40.8548254},{"ts":"2026-07-01","kind":"sec.form144","reporter":"SUSAN BOBULSKY","title":"Officer","shares":487,"usd_value":10446,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006690","importance":40.00208923},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"LO FRANCIS","title":"Chief People Officer","shares":42261,"price_per_share":22.5,"usd_value":950873,"security_title":"Common Stock","importance":35.9508725},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"LO FRANCIS","title":"Chief People Officer","shares":8743,"price_per_share":22.18,"usd_value":193920,"security_title":"Common Stock","importance":35.19391974},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"BOBULSKY SUSAN","title":"Chief Commercial Officer, MRD","shares":487,"price_per_share":22,"usd_value":10714,"security_title":"Common Stock","importance":35.010714},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-07-01","url_slug":"/sec/cik-0001478320/144/0001950047-26-006690","accession_number":"0001950047-26-006690","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-07-01","url_slug":"/sec/cik-0001478320/144/0001950047-26-006726","accession_number":"0001950047-26-006726","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":14064,"price_per_share":8.12,"usd_value":114200,"security_title":"Common Stock","importance":15.11419968},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":12206,"price_per_share":8.46,"usd_value":103263,"security_title":"Common Stock","importance":15.10326276},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":3300,"price_per_share":12.14,"usd_value":40062,"security_title":"Common Stock","importance":15.040062},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":3500,"price_per_share":7.8,"usd_value":27300,"security_title":"Common Stock","importance":15.0273},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"LO FRANCIS","title":"Chief People Officer","shares":4688,"price_per_share":3.99,"usd_value":18705,"security_title":"Common Stock","importance":15.01870512},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-06-30","url_slug":"/sec/cik-0001478320/4/0001780854-26-000008","accession_number":"0001780854-26-000008","importance":30},{"ts":"2026-06-29","kind":"sec.form144","reporter":"SHARON BENZENO","title":"Officer","shares":152931,"usd_value":3205434,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006622","importance":40.641086752},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"BENZENO SHARON","title":"Chief Commercial Ofc Imm Med","shares":154768,"price_per_share":21.14,"usd_value":3271796,"security_title":"Common Stock","importance":38.27179552},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-06-29","url_slug":"/sec/cik-0001478320/144/0001950047-26-006622","accession_number":"0001950047-26-006622","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-06-29","url_slug":"/sec/cik-0001478320/4/0001820885-26-000012","accession_number":"0001820885-26-000012","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"BENZENO SHARON","title":"Chief Commercial Ofc Imm Med","shares":51570,"price_per_share":8.12,"usd_value":418748,"security_title":"Common Stock","importance":15.4187484},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"BENZENO SHARON","title":"Chief Commercial Ofc Imm Med","shares":24944,"price_per_share":8.46,"usd_value":211026,"security_title":"Common Stock","importance":15.21102624},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"BENZENO SHARON","title":"Chief Commercial Ofc Imm Med","shares":24944,"price_per_share":3.99,"usd_value":99527,"security_title":"Common Stock","importance":15.09952656},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"BENZENO SHARON","title":"Chief Commercial Ofc Imm Med","shares":1837,"price_per_share":12.14,"usd_value":22301,"security_title":"Common Stock","importance":15.02230118},{"ts":"2026-06-26","kind":"sec.form144","reporter":"SHARON BENZENO","title":"Officer","shares":12871,"usd_value":260638,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006564","importance":40.05212755},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BENZENO SHARON","title":"Chief Commercial Ofc Imm Med","shares":11034,"price_per_share":21,"usd_value":231714,"security_title":"Common Stock","importance":35.231714},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"BENZENO SHARON","title":"Chief Commercial Ofc Imm Med","shares":11034,"price_per_share":12.14,"usd_value":133953,"security_title":"Common Stock","importance":15.13395276},{"ts":"2026-06-25","kind":"sec.form144","reporter":"MICHELLE GRIFFIN","title":"Director","shares":52084,"usd_value":1007305,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006507","importance":40.201460912},{"ts":"2026-06-25","kind":"sec.form144","reporter":"SUSAN BOBULSKY","title":"Officer","shares":5000,"usd_value":96700,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006508","importance":40.01934},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"GRIFFIN MICHELLE RENEE","title":null,"shares":52084,"price_per_share":20.18,"usd_value":1051055,"security_title":"Common Stock","importance":36.05105512},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"BOBULSKY SUSAN","title":"Chief Commercial Officer, MRD","shares":5000,"price_per_share":20.5,"usd_value":102500,"security_title":"Common Stock","importance":35.1025},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-06-25","url_slug":"/sec/cik-0001478320/144/0001950047-26-006508","accession_number":"0001950047-26-006508","importance":30},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"GRIFFIN MICHELLE RENEE","title":null,"shares":52084,"price_per_share":7.8,"usd_value":406255,"security_title":"Common Stock","importance":15.4062552},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Adaptive Biotechnologies Corp — 2026-06-22","url_slug":"/sec/cik-0001478320/8-k/0001193125-26-277516","accession_number":"0001193125-26-277516","importance":35},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-06-17","url_slug":"/sec/cik-0001478320/4/0001780851-26-000013","accession_number":"0001780851-26-000013","importance":30},{"ts":"2026-06-16","kind":"sec.form144","reporter":"Harlan Robins","title":"Officer","shares":6160,"usd_value":106075,"security_title":"Common Stock","approx_sale_date":"2026-06-16","accession_number":"0001958244-26-000386","importance":40.02121504},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":6160,"price_per_share":18.01,"usd_value":110942,"security_title":"Common Stock","importance":35.1109416},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-06-16","url_slug":"/sec/cik-0001478320/144/0001958244-26-000386","accession_number":"0001958244-26-000386","importance":30},{"ts":"2026-06-15","kind":"sec.form144","reporter":"Harlan Robins","title":"Officer","shares":100000,"usd_value":1746000,"security_title":"Common Stock","approx_sale_date":"2026-06-15","accession_number":"0001958244-26-000379","importance":40.3492},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"ROBINS HARLAN S","title":"Chief Scientific Officer","shares":100000,"price_per_share":17.37,"usd_value":1737000,"security_title":"Common Stock","importance":36.737},{"ts":"2026-06-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Adaptive Biotechnologies Corp — 2026-06-15","url_slug":"/sec/cik-0001478320/8-k/0001193125-26-271117","accession_number":"0001193125-26-271117","importance":35},{"ts":"2026-06-15","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-06-15","url_slug":"/sec/cik-0001478320/144/0001958244-26-000379","accession_number":"0001958244-26-000379","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Adaptive Biotechnologies Corp — 2026-06-15","url_slug":"/sec/cik-0001478320/4/0001820885-26-000010","accession_number":"0001820885-26-000010","importance":30},{"ts":"2026-06-11","kind":"sec.form144","reporter":"SUSAN BOBULSKY","title":"Officer","shares":5000,"usd_value":85350,"security_title":"Common","approx_sale_date":"2026-06-11","accession_number":"0001950047-26-005958","importance":40.01707},{"ts":"2026-06-11","kind":"sec.insider.s","reporter":"BOBULSKY SUSAN","title":"Chief Commercial Officer, MRD","shares":5000,"price_per_share":19,"usd_value":95000,"security_title":"Common Stock","importance":35.095},{"ts":"2026-06-11","kind":"sec.filing","form_type":"144","title":"144 — Adaptive Biotechnologies Corp — 2026-06-11","url_slug":"/sec/cik-0001478320/144/0001950047-26-005958","accession_number":"0001950047-26-005958","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Adaptive Biotechnologies Corp — 2026-06-09","url_slug":"/sec/cik-0001478320/8-k/0001193125-26-263844","accession_number":"0001193125-26-263844","importance":35}]}